OTC · IMPZY
Healthcare · Medical - Devices
$0.08
Up+$0.00 (+0.00%)
Updated Sep 12, 2026, 3:05 PM
SID Score
4.2/10
Composite research score
Smart Money
—
Institutional and insider signal
Price performance
1M range · 0 trading sessions · Daily adjusted prices
IMPZY does not have enough price history for the selected period.
Data unavailable
Market data is busy. Please try again shortly.
The latest Smart Investors Daily articles mentioning IMPZY.
IMPZY research
Company profile and research snapshot.
IMPLANET SA SPNS/ADR
Visit company websiteConsensus and target data currently published for this company.
No generated briefing is available yet.
Yahoo · Jan 13, 2026
BORDEAUX, France & BOSTON, January 13, 2026--Regulatory News: IMPLANET (Euronext Growth: ALIMP, FR0013470168, eligible for PEA-PME), a medical technology company specializing in implants for orthopedic surgery and the distribution of advanced medical equipment, today announces its full-year 2025 revenue as well as its cash position as of December 31, 2025.
Yahoo · Jan 6, 2026
BORDEAUX, France & BOSTON, January 06, 2026--Regulatory News: IMPLANET (Euronext Growth: ALIMP, FR0013470168, eligible for PEA-PME equity savings plans), a medical technology company specializing in implants for orthopedic surgery and the distribution of technological medical equipment, today announces its schedule for the publication of financial information for 2026.
Yahoo · Nov 13, 2025
BORDEAUX, France & BOSTON, November 13, 2025--Regulatory News: IMPLANET (Euronext Growth: ALIMP, FR0013470168, eligible for PEA-PME), a medical technology company specializing in implants for orthopedic surgery and the distribution of advanced medical equipment, today announced the signing of a partnership agreement with 8i Robotics Inc. The first milestone of this agreement focuses on clinical research aimed at achieving European regulatory compliance for a surgeon-supervised robot designed for
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
The latest Smart Investors Daily articles mentioning IMPZY.
No results
No recent SID articles mention IMPZY.
